CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹12 Cr | - | ₹332 Cr | ₹376 Cr | ₹355 Cr |
What is the latest Secured Loans ratio of CIPLA ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | - |
| Mar2023 | ₹332 Cr |
| Mar2022 | ₹376 Cr |
| Mar2021 | ₹355 Cr |
How is Secured Loans of CIPLA Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹332 Cr | -11.63 | |
| Mar2022 | ₹376 Cr | 5.88 | |
| Mar2021 | ₹355 Cr | - | |
Compare Secured Loans of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹106,035.9 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| MANKIND PHARMA | ₹91,867.7 Cr | 2.3% | 6.7% | -3.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -2.5% |
0.1% |
-7.6% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses